14-day Premium Trial Subscription Try For FreeTry Free

Explanation to Bollinger's Bands

Bollinger Bands was created by John Bollinger in the early 1980s, its purpose is to define price action relative to the assets highs and lows. This technical indicator is used to identify buy and sell signals and has proven very well in doing so.

Bollinger Bands consist of a set of three curves drawn in relation to securities prices. The middle band is a measure of the intermediate-term trend, usually a simple moving average, that serves as the base for the upper and lower bands. The interval between the upper and lower bands and the middle band is determined by volatility, typically the standard deviation of the same data that were used for the average. StockInvest.us uses Bollingers suggested 20 day average.

Middle Bollinger Band = 20-period simple moving average
Upper Bollinger Band = Middle Bollinger Band + 2 * 20-period standard deviation
Lower Bollinger Band = Middle Bollinger Band - 2 * 20-period standard deviation

BandWidth defines the current width of the band.
%b defines the current position within the band.

BandWidth = (Upper Bollinger Band - Lower Bollinger Band) / Middle Bollinger Band
%b = (Last - Lower Bollinger Band) / (Upper Bollinger Band - Lower Bollinger Band)

Live Samples:

Bollinger Bottleneck Buy Pattern 1
Bollinger Bottleneck Buy Pattern 2
Bollinger Bottleneck Sell Pattern

Bottlenecks in bandwidth indicate an upcoming change. Break up through the moving average line or continuous movements above the moving average line indicate a break up, and vice versa.

Source: http://www.bollingerbands.com

RSI low/high Values: [ 20 - 80 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of MOR.DE
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

MorphoSys AG stock price up 0.375% on Monday
(Updated on May 06, 2024)

Sell candidate since Apr 29, 2024 Gain 1.90% PDF

The MorphoSys AG stock price gained 0.375% on the last trading day (Monday, 6th May 2024), rising from 66.65€ to 66.90€. During the last trading day the stock fluctuated 0.83% from a day low at 66.40€ to a day high of 66.95€. The price has risen in 6 of the last 10 days but is still down by -1.18% for this period. Volume fell on the last day by -26 thousand shares and in total, 47 thousand shares were bought and sold for approximately 3.12€ million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the middle of a narrow and weak rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 4.88% during the next 3 months and, with a 90% probability hold a price between 69.08€ and 72.05€ at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

MOR.DE Signals & Forecast

Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely. Some negative signals were issued as well, and these may have some influence on the near short-term development. The MorphoSys AG stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at 67.10€. On a fall, the stock will find some support from the short-term average at 66.73€. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. A sell signal was issued from a pivot top point on Monday, April 15, 2024, and so far it has fallen -1.55%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for MorphoSys AG stock

MorphoSys AG finds support from accumulated volume at 66.40€ and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

In general the stock tends to have very controlled movements and with good liquidity the risk is considered very low in this stock. During the last day, the stock moved 0.550€ between high and low, or 0.83%. For the last week the stock has had daily average volatility of 1.78%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (MOR.DE) For The Upcoming Trading Day Of Tuesday 7th

For the upcoming trading day on Tuesday, 7th we expect MorphoSys AG to open at 66.75€, and during the day (based on 14 day Average True Range), to move between 66.36€ and 67.44€, which gives a possible trading interval of +/-0.542€ (+/-0.81%) up or down from last closing price. If MorphoSys AG takes out the full calculated possible swing range there will be an estimated 1.62% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at 67.18€ (0.42%) than the support at 66.40€ (0.75%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is MorphoSys AG stock A Buy?

The MorphoSys AG stock holds several negative signals and despite the positive trend, we believe MorphoSys AG will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Current score: -3.220 Sell Candidate Unchanged

Predicted Opening Price for MorphoSys AG of Tuesday, May 7, 2024

Fair opening price May 7, 2024 Current price
66.75€ ( 0.224%) 66.90€

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for MOR.DE

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 67.30 0.598 %
R2 67.09 0.284 %
R1 66.96 0.0898 %
Current price: 66.90
Support S1 66.54 -0.538 %
S2 66.41 -0.732 %
S3 66.20 -1.05 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 67.95 1.57 %
R2 67.70 1.20 %
R1 67.18 0.419 %
Current price 66.90
Support S1 66.40 -0.747%
S2 65.65 -1.87%
S3 63.50 -5.08%

FAQ

What is the symbol for MorphoSys AG Stock and on which exchange is it traded?
The symbol for MorphoSys AG is MOR.DE and it is traded on the GER (Deutsche Börse XETRA).

Should I buy or sell MorphoSys AG Stock?
The MorphoSys AG stock holds several negative signals and despite the positive trend, we believe MorphoSys AG will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

How to buy MorphoSys AG Stock?
MorphoSys AG Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy MorphoSys AG Stock.

What's the current price of MorphoSys AG Stock?
As of the end of day on the May 06, 2024, the price of an MorphoSys AG (MOR.DE) share was 66.90€.

What is the 52-week high and low for MorphoSys AG Stock?
The 52-week high for MorphoSys AG Stock is 95.57€ and the 52-week low is 69.42€.

What is the market capitalization of MorphoSys AG Stock?
As of the May 06, 2024, the market capitalization of MorphoSys AG is 2.52B.

When is the next earnings date for MorphoSys AG?
The upcoming earnings date for MorphoSys AG is Aug 08, 2024.
Click to get the best stock tips daily for free!

About MorphoSys AG

MorphoSys AG MorphoSys AG, a commercial-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic antibodies for patients suffering from cancer and autoimmune diseases in the United States. It offers Tafasitamab, an antibody for the treatment of B cell malignancies, including diffuse large B-cell lymphoma, follicular lymphoma, and marginal zone lymphoma. The company also develops Pelabresib, a small molecule ... MOR.DE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT